Kennel Cough Vaccine for Dogs

Naramune-2 is a vaccine against canine parainfluenza and Bordetella bronchiseptica. It is administered intranasally to immunize dogs against various types of canine upper respiratory tract infections and kennel cough. Initial vaccinations with Naramune-2 may be given at 3 weeks of age.

Naramune-2 protects dogs and puppies against canine upper respiratory infections, otherwise known as canine cough or kennel cough, caused by parainfluenza and Bordetella bronchiseptica. This intranasal vaccine is safe for use in healthy dogs and puppies as young as 3 weeks of age.

Benefits of Naramune-2:

  • Vaccinates against canine parainfluenza and Bordetella bronchiseptica
  • Prevents some types of common respiratory infections and kennel cough
  • Helps keep dogs healthy
  • Helps protect other animals in the household
  • Protects your dog during boarding and other circumstances of close contact with other dogs
  • Avoids hassles and costs associated with these illnesses and their treatment
  • Administered intranasally, not requiring injection

Read all label instructions and precautionary statements prior to use.

For use by or under the close supervision of a veterinarian.


  1. Reconstitute vaccine with included sterile diluent to desired volume. For five 0.5-mL doses, rehydrate with 2.5 mL diluent; for five 1-mL doses, rehydrate with 5 mL diluent.
  2. Shake well and use product right away.
  3. Use the manufacturer-provided nasal applicator in place of syringe needle.
  4. Administer aseptically via the nasal passage.

Frequency of Use:

Initial vaccination may be made at 3 weeks of age. Puppies vaccinated before 6 weeks of age should receive a second dose at this time. Annual boosters are recommended.


Keep out of reach of children and animals.

Refrigerate Naramune-2 between 35 and 45 degrees F. Do not freeze. Protect from sunlight. Use upon opening.

Incinerate containers and any unused content.

It is a violation of Federal Law to use this product in a manner inconsistent with its labeling.

Naramune-2 contains modified live virus and avirulent live culture. It introduces a dog's immune system to canine parainfluenza and Bordetella bronchiseptica in a controlled manner that elicits a rapid, effective immune response to these pathogens in the event of subsequent exposure.

Naramune-2 contains canine parainfluenza-Bordetella Bronchiseptica Vaccine, modified live virus, avirulent live culture, and neomycin as a preservative.


Keep Naramune-2 out of reach of children and animals. Do not use or store in or near open flame or heat.

Naramune-2 is only intended for administration to healthy dogs and puppies at least 3 weeks of age. Do not use in younger puppies or in other species. Not for use in humans.

Follow product and veterinarian directions.

CAUTION: Epinephrine is indicated in the event of an anaphylactoid reaction.

Very rarely, vaccinated dogs may experience sneezing, coughing, or nasal discharge for 3 to 10 days following administration. Antibacterial therapy may be indicated.

Use contents right away upon opening and reconstitution.

Burn containers and unused product.

Warranty and Manufacturer Information:

Boehringer Ingelheim

U.S. Vet. Lic. No.: 124

10423-01 / 10421-01 / 10422-01

NAC No.: 10280791

Products 1-2 of 2
Naramune 2 - 25 ds Tray
Retail: $199.99
Retail: $199.99
Price: $144.55 Save: $55.44

use coupon:

estimated: $ 144.55

Availability: Back Order
Availability: Back Order
Boehringer Ingelheim Item #: 1040174 -

Naramune 2 - 5 ds Vial
Retail: $51.99
Retail: $51.99
Price: $37.11 Save: $14.88

use coupon:

estimated: $ 37.11

Availability: Back Order
Availability: Back Order
Boehringer Ingelheim Item #: 1040173 -

Customer ServiceFree Shipping

The VetDepot Difference